Evidence map›Paper›PMID 26659073›Full record

ArticlePloS one2015

Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model.

Merel Huisman, Robert M Staruch, Michelle Ladouceur-Wodzak, Maurice A van den Bosch, Dennis K Burns, Avneesh Chhabra, Rajiv Chopra

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. MRI-guided focused ultrasound ablation of lumbar medial branch nerve: Feasibility and safety study in a swine model.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Merel HuismanDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Robert M StaruchDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Michelle Ladouceur-WodzakDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Maurice A van den BoschDepartment of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Dennis K BurnsDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Avneesh ChhabraDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX, United States of America.
Rajiv ChopraDepartment of Radiology, UT Southwestern Medical Center, Dallas, TX, United States of America.

Funding

Image-guided doxorubicin delivery for pediatric sarcomasR01CA199937 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHOPRA, RAJIV, LAETSCH, THEODORE WILLIS · 2015 to 2019
$2.8M
NCI NIH HHS R01 CA199937
6 · The paper itself

Abstract

purposeUltrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system.

methodsVolumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160-300 W). Peripheral nerves were extracted < 3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson's trichrome and toluidine blue staining.

resultsAll targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7°C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation.

conclusionOur preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection.

Indexed as

AnimalsDisease Models, AnimalFemaleHigh-Intensity Focused Ultrasound AblationHindlimbHistocytochemistryMagnetic Resonance ImagingNeuralgiaNeuroimagingPeripheral NervesPilot ProjectsSwineTemperatureUltrasonic Waves

Identifiers

PMID26659073
PMCPMC4682836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.